Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 444.80
Bid: 446.60
Ask: 447.40
Change: 3.60 (0.82%)
Spread: 0.80 (0.179%)
Open: 441.20
High: 447.80
Low: 439.80
Prev. Close: 441.20
PAGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

17 Sep 2008 11:58

RNS Number : 6427D
Credit Suisse Securities (Eur) Ltd
17 September 2008
 

FORM 38.5 (b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION 

Name of exempt principal trader

Credit Suisse Securities (Europe) Limited

 

Company dealt in

Michael Page International Plc

 

Class of relevant security to which the dealings being disclosed relate (Note 1)

 

Ordinary Shares

Date of dealing

16-Sep-2008

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

77795

0.024

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell 

 

 

 

 

Total

 

 

77795

0.024

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) 

Class Of Relevant Security : 

Long

Short

(1) Relevant Securities 

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchasesell 

 

 

Total

 

 

(c) Rights to subscribe (Note 2) 

Class of relevant security:

Details

 

 

3. DEALINGS (Note 3)

(a) Purchases and sales 

Purchase/sale

Number of securities

Price per unit (Note 4)

Buy

6851

2.5025 (GBP)

Buy

4435

2.5025 (GBP)

Buy

4069

2.5025 (GBP)

Buy

3065

2.4925 (GBP)

Buy

2949

2.4925 (GBP)

Buy

2887

2.5025 (GBP)

Buy

1925

2.5025 (GBP)

Buy

1925

2.5025 (GBP)

Buy

1722

2.485 (GBP)

Buy

807

2.415 (GBP)

Buy

751

2.4375 (GBP)

Buy

708

2.4225 (GBP)

Buy

676

2.42 (GBP)

Buy

675

2.42 (GBP)

Buy

647

2.41 (GBP)

Buy

223

2.41 (GBP)

Sell

10433

2.5 (GBP)

Sell

10170

2.59 (GBP)

Sell

4002

2.5 (GBP)

Sell

2504

2.5775 (GBP)

Sell

1975

2.5775 (GBP)

Sell

744

2.59 (GBP)

Total Buys: 34315

Total Sells: 29828

(b) Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

 

 

 

 

(c) Options transactions in respect of existing securities 

(i) Writing, selling, purchasing or varying 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 6)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

(ii) Exercising 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

(d) Other dealings (including new securities) (Note 3) 

Nature of transaction (Note 7)

Details

Price per unit (if applicable) (Note 4)

 

 

 

4. OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8)  No

Date of disclosure

 17.09.08

 

Contact name

 Simon Crawley; Philipp Abelbeck

 

Telephone number

 020 7888 5416

 

Name of offeree/offeror with which connected

Adecco

 

Nature of connection (Note 9)

ADVISOR

Notes 

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMSFMFSWSASEIU
Date   Source Headline
10th Jun 20243:28 pmRNSDirector Declaration
3rd Jun 20241:50 pmRNSResult of AGM
15th Apr 20247:00 amRNSTrading Update
12th Apr 20243:48 pmRNSAnnual Report & Accounts & Notice of AGM
11th Apr 202411:18 amRNSHolding(s) in Company
11th Apr 20249:30 amRNSNotice of First Quarter 2024 Trading Update
18th Mar 20242:20 pmRNSDirector/PDMR Shareholding
18th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 202412:17 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFull Year Results for the Year Ended 31 Dec 2023
4th Mar 20243:18 pmRNSNotice of 2023 Full Year Results
15th Jan 20247:00 amRNSTrading Update
11th Jan 20249:43 amRNSNotice of Q4 and Full Year 2023 Trading Update
27th Nov 20231:59 pmRNSHolding(s) in Company
11th Oct 20237:00 amRNSQ3 Trading Statement
10th Oct 20239:53 amRNSNotice of Third Quarter 2023 Trading Update
27th Sep 20233:00 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSCapital Markets Event
7th Aug 20232:52 pmRNSHolding(s) in Company
7th Aug 20237:00 amRNSHalf Year Results for the Period Ended 30 June 23
2nd Aug 20234:27 pmRNSNotice of 2023 Half Year Results
20th Jul 20232:18 pmRNSHolding(s) in Company
18th Jul 20233:23 pmRNSHolding(s) in Company
18th Jul 20231:57 pmRNSHolding(s) in Company
12th Jul 202311:27 amRNSHolding(s) in Company
12th Jul 20237:00 amRNSTrading Update
10th Jul 202310:18 amRNSNotice of Second Quarter 2023 Trading Update
20th Jun 20233:36 pmRNSHolding(s) in Company
14th Jun 202311:51 amRNSHolding(s) in Company
6th Jun 20237:00 amRNSInteractive Investor Event
1st Jun 20231:47 pmRNSResult of AGM
19th Apr 20234:25 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSQ1 Trading Statement
13th Apr 20232:19 pmRNSNotice of First Quarter 2023 Trading Update
13th Apr 202310:35 amRNSAnnual Report & Accounts & Notice of AGM
3rd Apr 20235:42 pmRNSHolding(s) in Company
24th Mar 202310:41 amRNSDirector/PDMR Shareholding
23rd Mar 202312:45 pmRNSHolding(s) in Company
16th Mar 202312:34 pmRNSDirector/PDMR Shareholding
16th Mar 202312:28 pmRNSDirector/PDMR Shareholding
14th Mar 202312:37 pmRNSDirector/PDMR Shareholding
14th Mar 202312:35 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSFull Year Results for the Year Ended 31 Dec 2022
7th Mar 20235:37 pmRNSBoard Changes
2nd Mar 20231:55 pmRNSNotice of 2022 Full Year Results
11th Jan 20237:00 amRNSFOURTH QUARTER AND FULL YEAR 2022 TRADING UPDATE
9th Jan 20232:23 pmRNSNotice of Q4 and Full Year 2022 Trading Update
23rd Dec 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSAppointment of Chief Executive Officer Designate
12th Oct 20227:00 amRNSThird Quarter 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.